Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nicolas Alan Menzies, Ph.D.

Concepts (185)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Tuberculosis20202014854.600 Why?
Immunization Programs620192232.460 Why?
Models, Theoretical17202034052.340 Why?
Health Care Costs11201928531.700 Why?
Infant Care220171771.350 Why?
Latent Tuberculosis420201231.350 Why?
Cost-Benefit Analysis12202047911.290 Why?
Health Policy8202024031.250 Why?
Developing Countries5201924441.100 Why?
Epidemics320204020.960 Why?
Mycobacterium tuberculosis5201916180.810 Why?
Bayes Theorem4202014510.770 Why?
Health Resources220168730.750 Why?
Antitubercular Agents7201811250.720 Why?
Clinical Laboratory Techniques220126160.680 Why?
Decision Theory12015290.680 Why?
Quality-Adjusted Life Years5201714070.630 Why?
Delivery of Health Care4201934860.600 Why?
Emigrants and Immigrants120183480.590 Why?
HIV Infections122018135390.550 Why?
Antibiotics, Antitubercular12012960.530 Why?
Chlamydia Infections320192990.500 Why?
Income1201915200.500 Why?
Vaccination2201917930.490 Why?
Rifampin120122560.480 Why?
Mortality2202023550.480 Why?
Uganda520178620.470 Why?
Policy Making420204920.470 Why?
Tuberculosis, Pulmonary220197590.470 Why?
Lung Diseases1202018070.440 Why?
Models, Statistical5202047480.420 Why?
Moldova22017160.400 Why?
Honduras22017330.400 Why?
Health Services Needs and Demand1201613630.390 Why?
Computational Biology1202031920.380 Why?
Pulmonary Disease, Chronic Obstructive1202023790.360 Why?
Mass Screening6201945690.360 Why?
Immunoassay120096970.330 Why?
South Africa7202013300.330 Why?
Anti-HIV Agents4201537160.330 Why?
Drug Resistance, Bacterial120129510.320 Why?
Vaccines320194570.310 Why?
Health Facilities220172970.310 Why?
Vietnam320133850.290 Why?
Zambia320191920.280 Why?
HIV Antibodies1200910710.280 Why?
HIV-12201163430.280 Why?
Incidence102020184120.270 Why?
Costs and Cost Analysis2201915050.270 Why?
Disease Progression22019118620.260 Why?
Goals220165400.260 Why?
Humans4620206024210.260 Why?
Ethiopia220122880.250 Why?
Decision Making4202036660.250 Why?
India5201818330.240 Why?
Infant72020304090.240 Why?
Contact Tracing220191580.240 Why?
Nigeria220124560.230 Why?
Isoniazid220182080.220 Why?
Botswana220127290.220 Why?
Puerto Rico120202960.220 Why?
Anti-Retroviral Agents3201413760.210 Why?
Polymerase Chain Reaction1200966010.210 Why?
Benin12017100.200 Why?
Africa South of the Sahara220175300.200 Why?
Aftercare120203130.200 Why?
Chlamydia12017270.190 Why?
Tuberculin Test120181790.190 Why?
Health Planning120192300.190 Why?
Chlamydia trachomatis120192170.190 Why?
Ghana120171940.190 Why?
Dengue120202120.190 Why?
Capacity Building120192110.180 Why?
Health Status1201037020.180 Why?
Prevalence62020132290.180 Why?
Gonorrhea120182310.180 Why?
Secondary Prevention2202013860.170 Why?
Emigration and Immigration120183560.170 Why?
California1202013100.170 Why?
Morbidity1202014110.160 Why?
Calibration120177740.160 Why?
Achievement120163030.160 Why?
AIDS-Related Opportunistic Infections120186930.150 Why?
Disease Transmission, Infectious120194120.150 Why?
China2201620290.150 Why?
Likelihood Functions120179620.150 Why?
Efficiency, Organizational120197070.150 Why?
Africa, Southern12012440.140 Why?
Decision Trees120154870.140 Why?
Mozambique12012440.140 Why?
Diagnostic Tests, Routine120196430.140 Why?
Bacteriological Techniques120142970.140 Why?
Cause of Death2202031630.130 Why?
Health Services Accessibility3201742150.130 Why?
United States52020559490.130 Why?
Quality of Life1201085740.130 Why?
Tuberculosis, Multidrug-Resistant120187680.120 Why?
Research1202019680.120 Why?
Sputum120124170.120 Why?
Diagnostic Errors1201912280.120 Why?
Value of Life120101230.120 Why?
Influenza, Human1202010730.120 Why?
Forecasting2201627460.120 Why?
Host-Pathogen Interactions1201912590.120 Why?
Early Diagnosis2201910670.110 Why?
Population Surveillance2201826670.110 Why?
Tissue Plasminogen Activator1201713060.110 Why?
Monte Carlo Method1201512510.110 Why?
Software2202039800.110 Why?
Decision Support Techniques1202018590.110 Why?
Health Expenditures2201618090.100 Why?
Regression Analysis1201766420.090 Why?
Fibrinolytic Agents1201719710.090 Why?
Health Personnel1201721800.080 Why?
Research Design1202052400.080 Why?
Quality Improvement1201929630.080 Why?
Sexual Partners220196140.080 Why?
Antiretroviral Therapy, Highly Active1201319010.070 Why?
Patient Acceptance of Health Care1201624640.070 Why?
Brain Ischemia1201729580.070 Why?
CD4 Lymphocyte Count3201425330.070 Why?
Child, Preschool32020372740.070 Why?
DNA, Viral1200922770.060 Why?
Linear Models1201259790.060 Why?
Adolescent52020760140.060 Why?
Young Adult42020472260.060 Why?
Reproducibility of Results12019178200.060 Why?
Child42020617540.060 Why?
Practice Guidelines as Topic2201468680.050 Why?
Catastrophic Illness12017360.050 Why?
Adult720201912240.050 Why?
Africa, Western120161340.050 Why?
Nutrition Therapy12016750.040 Why?
Stroke1201779020.040 Why?
Viral Load2201427040.040 Why?
Drug Therapy, Combination2201863030.040 Why?
Risk Factors22019619760.040 Why?
Male820193199540.040 Why?
Disease Management2201622010.040 Why?
Rural Health Services120173380.040 Why?
Communicable Disease Control120184850.040 Why?
Female820193376860.040 Why?
Treatment Outcome52018539630.040 Why?
Markov Chains120179500.040 Why?
Sensitivity and Specificity12009146840.040 Why?
Epidemiologic Methods1201914240.040 Why?
Politics120196820.030 Why?
Nutrition Surveys1201912550.030 Why?
Comorbidity2201995940.030 Why?
Qualitative Research1201916590.030 Why?
HIV Seropositivity120178870.030 Why?
Interviews as Topic1201925490.030 Why?
HIV1201812900.030 Why?
Drug Substitution120132420.030 Why?
Health Priorities120143870.030 Why?
World Health Organization1201611310.030 Why?
Middle Aged320201955180.030 Why?
Terminology as Topic1201916260.030 Why?
Aged220201439210.030 Why?
Eligibility Determination120133300.030 Why?
Models, Economic120146650.030 Why?
Causality120159700.030 Why?
Sexual Behavior1201816070.030 Why?
Infant, Newborn22018214600.030 Why?
Counseling1201713510.030 Why?
Microbial Sensitivity Tests1201417190.030 Why?
Rural Population1201716350.020 Why?
Ethnic Groups1201828230.020 Why?
Feasibility Studies1201542040.020 Why?
Disease Outbreaks1201514880.020 Why?
Referral and Consultation1201728660.020 Why?
Computer Simulation1201557570.020 Why?
Age Factors12018179920.010 Why?
Randomized Controlled Trials as Topic1201781890.010 Why?
Survival Rate12015123450.010 Why?
Survival Analysis12014101000.010 Why?
Diet1201664040.010 Why?
Biomedical Research1201428470.010 Why?
Hospitalization1201671200.010 Why?
Predictive Value of Tests12014141900.010 Why?
Time Factors12017402610.010 Why?
Prognosis12014255410.010 Why?
Risk Assessment12015206940.010 Why?
Retrospective Studies12019533530.010 Why?
Aged, 80 and over12017531210.010 Why?
Menzies's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (185)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.